GGrantIndex
Sort

40,608 grants matching prostate cancer

STAT1 Activation and HPP1 Tumor Suppression

$315,962
David Shibata · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA

Targets for selenium in prostate cancer prevention

$315,942
John T Pinto · Winifred Masterson Burke Med Res Inst · R01 · FY2006 · CA

Alterations in CD4 T cells during sepsis

$315,934
Thomas S Griffith · University Of Minnesota · R01 · FY2016 · GM

Paracrine TGF-Beta Signaling in Breast Cancer Initiation and Progression

$315,928
Harold L Moses · Vanderbilt University · U54 · FY2009 · CA

Prostate carcinogenesis and PKC signaling

$315,877
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2014 · CA

Combining Virotherapy and Immunotherapy for Cancer

$315,871
University Of California Los Angeles · R01 · FY2005 · CA

Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy

$315,862
Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2020 · CA

SFSU/UCSF Comprehensive Cancer Partnership Program

$315,846
University Of California San Francisco · U56 · FY2005 · CA

A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesis

$315,839
Zijie Sun · Stanford University · R01 · FY2013 · CA

Project 4: Immunovirotherapy

$315,793
Richard G Vile · Mayo Clinic Rochester · P50 · FY2020 · CA

Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI

$315,770
Jeanine M. Genkinger · Columbia University Health Sciences · R01 · FY2020 · CA

Studies of Non-Ionizing Radiation-Related Cancer

$315,747
Peter D Inskip · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Transcriptional Repression by Polycomb Group Products

$315,724
Jeffrey A Simon · University Of Minnesota · R01 · FY2011 · GM

Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression

$315,708
Lorelei Mucci · Brigham And Women'S Hospital · R01 · FY2013 · CA

Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma

$315,680
Hong Wu · University Of California Los Angeles · R01 · FY2010 · CA

Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma

$315,680
Hong Wu · University Of California Los Angeles · R01 · FY2008 · CA

Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma

$315,680
Hong Wu · University Of California Los Angeles · R01 · FY2009 · CA

The Role of Mechanotransduction in Progression of Tumor-induced Bone Disease

$315,650
Scott A Guelcher · Vanderbilt University · R01 · FY2016 · CA

Fluorescence Imaging to Optimize Cancer Therapy

$315,638
Dartmouth College · R01 · FY2005 · CA

Serum Antibody Profiling with a Carbohydrate Microarray

$315,615
Jeffrey Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Improving cancer survivorship care delivery in Latino survivors: telehealth & lay health educators

$315,575
Eric Jessen Chow · Fred Hutchinson Cancer Research Center · R21 · FY2021 · CA

Equol and Regulation of Prostate Growth

$315,566
Robert J Handa · University Of Arizona · R01 · FY2010 · CA

OV Therapy Induced Changes in Tumor Secretome and Their Impact on Therapy

$315,563
Balveen Kaur · Ohio State University · R01 · FY2010 · NS

Imaging, image guided biopsy and treatment of prostate cancer

$315,554
Baris Turkbey · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Vitamin D Status and Prostate Cancer

$315,551
James C Fleet · Purdue University · R01 · FY2008 · CA